Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-05-18 @ 2:57 PM
Study NCT ID:
NCT05554432
Status:
UNKNOWN
Last Update Posted:
2022-11-03
First Post:
2022-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2
Sponsor:
Institut Curie
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IC 2022-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None